A61K 47/34
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
Official title: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
A61K47/34 (Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds) appears on 3,951 US grants and 7,325 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,951
- Published applications
- 7,325
- Assignees
- 2,536
- Inventors
- 10,995
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 13 | 0 |
| 1990 | 11 | 0 |
| 1991 | 8 | 0 |
| 1992 | 3 | 0 |
| 1993 | 10 | 0 |
| 1994 | 11 | 0 |
| 1995 | 10 | 0 |
| 1996 | 7 | 0 |
| 1997 | 18 | 0 |
| 1998 | 18 | 0 |
| 1999 | 21 | 0 |
| 2000 | 10 | 0 |
| 2001 | 26 | 6 |
| 2002 | 36 | 54 |
| 2003 | 28 | 92 |
| 2004 | 29 | 121 |
| 2005 | 18 | 118 |
| 2006 | 39 | 127 |
| 2007 | 27 | 131 |
| 2008 | 31 | 174 |
| 2009 | 37 | 209 |
| 2010 | 64 | 197 |
| 2011 | 77 | 204 |
| 2012 | 118 | 239 |
| 2013 | 177 | 313 |
| 2014 | 251 | 397 |
| 2015 | 243 | 461 |
| 2016 | 250 | 402 |
| 2017 | 268 | 460 |
| 2018 | 276 | 401 |
| 2019 | 250 | 443 |
| 2020 | 259 | 495 |
| 2021 | 294 | 500 |
| 2022 | 242 | 394 |
| 2023 | 198 | 405 |
| 2024 | 224 | 395 |
| 2025 | 202 | 336 |
| 2026 | 132 | 251 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for laser lithotripsy using nanoparticle fine-tuned NIR absorption6 Oct 2026US 12,751,766 B2Duke University
- Medication that protects the intestinal microbiota and their preparation methods and applications6 Oct 2026US 12,751,921 B2University of Science and Technology of China
- Stable levothyroxine compositions in aprotic polar solvents6 Oct 2026US 12,751,937 B2Xeris Pharmaceuticals, Inc.
- Method of treating a child with central precocious puberty using an extended release composition6 Oct 2026US 12,751,990 B2Tolmar International Limited
- Pharmaceutical composition containing anionic drug, and preparation method therefor6 Oct 2026US 12,752,010 B2Samyang Holdings Corporation
- Amlodipine formulations8 Oct 2026US 2026/0306467 A1Azurity Pharmaceuticals, Inc.
- Ocular implant containing a tyrosine kinase inhibitor8 Oct 2026US 2026/0306469 A1Ocular Therapeutix, Inc.
- Lifitegrast-containing ink binder for ophthalmic devices8 Oct 2026US 2026/0306478 A1Bausch + Lomb Ireland Limited
- Pharmaceutical Composition for Vaccination against Cytomegalovirus Infections8 Oct 2026US 2026/0306606 A1Instar Technologies A.S.
- Ophthalmic device for treatment of dry eye1 Oct 2026US 2026/0294798 A1Bausch + Lomb Ireland Limited
Most cited
By later US patents
- Injectable microdispersions for soft tissue repair and augmentation1,443US 5,599,852 AEthicon, Inc. · 1997
- Injectable liquid copolymers for soft tissue repair and augmentation1,373US 5,824,333 AEthicon, Inc. · 1998
- Drug-delivering composite structures814US 9,446,226 B2Ramot at Tel-Aviv University Ltd. · 2016
- Biodegradable in-situ forming implants and methods of producing the same801US 4,938,763 A1990
- Polysiloxane hydrogels775US 4,136,250 ACiba-Geigy Corporation · 1979